Order Article Reprints

Gnanaraj C, Sekar M, Fuloria S, Swain SS, Gan SH, Chidambaram K, Rani NNIM, Balan T, Stephenie S, Lum PT, et al. In Silico Molecular Docking Analysis of Karanjin against Alzheimer’s and Parkinson’s Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy. Molecules. 2022; 27(9):2834. https://doi.org/10.3390/molecules27092834

Gnanaraj, Charles, Mahendran Sekar, Shivkanya Fuloria, Shasank S. Swain, Siew Hua Gan, Kumarappan Chidambaram, Nur Najihah Izzati Mat Rani, Tavamani Balan, Sarah Stephenie, Pei Teng Lum, and et al. 2022. "In Silico Molecular Docking Analysis of Karanjin against Alzheimer’s and Parkinson’s Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy" Molecules 27, no. 9: 2834. https://doi.org/10.3390/molecules27092834

Gnanaraj, C., Sekar, M., Fuloria, S., Swain, S. S., Gan, S. H., Chidambaram, K., Rani, N. N. I. M., Balan, T., Stephenie, S., Lum, P. T., Jeyabalan, S., Begum, M. Y., Chandramohan, V., Thangavelu, L., Subramaniyan, V., & Fuloria, N. K. (2022). In Silico Molecular Docking Analysis of Karanjin against Alzheimer’s and Parkinson’s Diseases as a Potential Natural Lead Molecule for New Drug Design, Development and Therapy. Molecules, 27(9), 2834. https://doi.org/10.3390/molecules27092834